Risk factors
Sonoma Pharmaceuticals (SNOA) risk factors
Item 1A of every Sonoma Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2026 10-K risk factors32 risks1 new1 dropped5 reworded
Product recalls, safety or efficacy allegations, mislabeling, and regulatory violations are newly highlighted as threats to sales and reputation.
Filed Jun 16, 2026 - FY2025 10-K risk factors32 risks
Sonoma Pharmaceuticals relies heavily on international sales, particularly in Mexico and Europe, exposing it to foreign exchange, tariff, and credit risks. The company faces a going concern warning with an accumulated deficit of $197,806,000 as of March 31, 2025. Significant customer concentration exists, with customer B and customer C accounting for 21% and 18% of net revenues.
Filed Jun 17, 2025